WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹175 Cr | ₹211 Cr | ₹320 Cr | ₹360 Cr | ₹355 Cr |
What is the latest Total Current Liabilities ratio of WANBURY ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹175 Cr |
| Mar2024 | ₹211 Cr |
| Mar2023 | ₹320 Cr |
| Mar2022 | ₹360 Cr |
| Mar2021 | ₹355 Cr |
How is Total Current Liabilities of WANBURY Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹175 Cr | -17.13 | |
| Mar2024 | ₹211 Cr | -34.16 | |
| Mar2023 | ₹320 Cr | -11.05 | |
| Mar2022 | ₹360 Cr | 1.24 | |
| Mar2021 | ₹355 Cr | - | |
Compare Total Current Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹870.1 Cr | -0% | -3.7% | 18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -0% |
-3.7% |
18.2% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses